Literature DB >> 21361892

Hierarchical commensurate and power prior models for adaptive incorporation of historical information in clinical trials.

Brian P Hobbs1, Bradley P Carlin, Sumithra J Mandrekar, Daniel J Sargent.   

Abstract

Bayesian clinical trial designs offer the possibility of a substantially reduced sample size, increased statistical power, and reductions in cost and ethical hazard. However when prior and current information conflict, Bayesian methods can lead to higher than expected type I error, as well as the possibility of a costlier and lengthier trial. This motivates an investigation of the feasibility of hierarchical Bayesian methods for incorporating historical data that are adaptively robust to prior information that reveals itself to be inconsistent with the accumulating experimental data. In this article, we present several models that allow for the commensurability of the information in the historical and current data to determine how much historical information is used. A primary tool is elaborating the traditional power prior approach based upon a measure of commensurability for Gaussian data. We compare the frequentist performance of several methods using simulations, and close with an example of a colon cancer trial that illustrates a linear models extension of our adaptive borrowing approach. Our proposed methods produce more precise estimates of the model parameters, in particular, conferring statistical significance to the observed reduction in tumor size for the experimental regimen as compared to the control regimen.
© 2011, The International Biometric Society.

Entities:  

Mesh:

Year:  2011        PMID: 21361892      PMCID: PMC3134568          DOI: 10.1111/j.1541-0420.2011.01564.x

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  6 in total

1.  Experience with reviewing Bayesian medical device trials.

Authors:  Gene Pennello; Laura Thompson
Journal:  J Biopharm Stat       Date:  2008       Impact factor: 1.051

2.  A note on the power prior.

Authors:  Beat Neuenschwander; Michael Branson; David J Spiegelhalter
Journal:  Stat Med       Date:  2009-12-10       Impact factor: 2.373

3.  A case for Bayesianism in clinical trials.

Authors:  D A Berry
Journal:  Stat Med       Date:  1993-08       Impact factor: 2.373

4.  Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group.

Authors:  L B Saltz; J V Cox; C Blanke; L S Rosen; L Fehrenbacher; M J Moore; J A Maroun; S P Ackland; P K Locker; N Pirotta; G L Elfring; L L Miller
Journal:  N Engl J Med       Date:  2000-09-28       Impact factor: 91.245

5.  A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer.

Authors:  Richard M Goldberg; Daniel J Sargent; Roscoe F Morton; Charles S Fuchs; Ramesh K Ramanathan; Stephen K Williamson; Brian P Findlay; Henry C Pitot; Steven R Alberts
Journal:  J Clin Oncol       Date:  2003-12-09       Impact factor: 44.544

Review 6.  Bayesian clinical trials.

Authors:  Donald A Berry
Journal:  Nat Rev Drug Discov       Date:  2006-01       Impact factor: 84.694

  6 in total
  52 in total

1.  Bayesian hierarchical classification and information sharing for clinical trials with subgroups and binary outcomes.

Authors:  Nan Chen; J Jack Lee
Journal:  Biom J       Date:  2018-12-03       Impact factor: 2.207

2.  Increasing efficiency for estimating treatment-biomarker interactions with historical data.

Authors:  Philip S Boonstra; Jeremy Mg Taylor; Bhramar Mukherjee
Journal:  Stat Methods Med Res       Date:  2014-05-21       Impact factor: 3.021

3.  Design and Evaluation of an External Control Arm Using Prior Clinical Trials and Real-World Data.

Authors:  Steffen Ventz; Albert Lai; Timothy F Cloughesy; Patrick Y Wen; Lorenzo Trippa; Brian M Alexander
Journal:  Clin Cancer Res       Date:  2019-06-07       Impact factor: 12.531

4.  Combining Non-randomized and Randomized Data in Clinical Trials Using Commensurate Priors.

Authors:  Hong Zhao; Brian P Hobbs; Haijun Ma; Qi Jiang; Bradley P Carlin
Journal:  Health Serv Outcomes Res Methodol       Date:  2016-08-06

5.  The volume-outcome relationship in laparoscopic cholecystectomy: a population-based study using propensity score matching.

Authors:  Hon-Yi Shi; King-Teh Lee; Chong-Chi Chiu; Hao-Hsien Lee
Journal:  Surg Endosc       Date:  2013-04-26       Impact factor: 4.584

6.  Detecting and accounting for violations of the constancy assumption in non-inferiority clinical trials.

Authors:  Joseph S Koopmeiners; Brian P Hobbs
Journal:  Stat Methods Med Res       Date:  2016-09-01       Impact factor: 3.021

7.  Improving Hierarchical Models Using Historical Data with Applications in High-Throughput Genomics Data Analysis.

Authors:  Ben Li; Yunxiao Li; Zhaohui S Qin
Journal:  Stat Biosci       Date:  2016-07-08

8.  Detecting outlying trials in network meta-analysis.

Authors:  Jing Zhang; Haoda Fu; Bradley P Carlin
Journal:  Stat Med       Date:  2015-04-08       Impact factor: 2.373

9.  A practical Bayesian adaptive design incorporating data from historical controls.

Authors:  Matthew A Psioda; Mat Soukup; Joseph G Ibrahim
Journal:  Stat Med       Date:  2018-07-22       Impact factor: 2.373

10.  Commensurate Priors on a Finite Mixture Model for Incorporating Repository Data in Clinical Trials.

Authors:  Byron J Gajewski; C Shane Reese; John Colombo; Susan E Carlson
Journal:  Stat Biopharm Res       Date:  2016-06-02       Impact factor: 1.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.